Abstract
BackgroundGlucocorticoids (GCs) are widely used in the management of patients with systemic sclerosis (SSc), but are frequently discontinuated because of patient and/or physician concern. Clinical consequences of GCs discontinuation have...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
